What one share of STAAR Surgical holds
STAAR generates worldwide revenue almost exclusively from sales of our Implantable Collamer Lenses, or “ICLs.” Our ICLs are made from Collamer, which is a proprietary collagen copolymer material created and
STAAR Surgical’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-07-03; the balance sheet is as of 2026-07-03.
| Sales | $6.73 |
|---|---|
| Profit | $0.08 |
| Capex (buildings and equipment) | $0.07 |
| Free cash flow | −$0.13 |
| Cash and investments | $2.96 |
| Book value | $7.29 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2009 | $1.57 | −$0.19 | $0.02 | $0.03 | — | $0.65 |
| 2011 | $1.70 | $0.04 | $0.03 | $0.12 | — | $0.82 |
| 2012 | $1.76 | −$0.05 | $0.06 | $0.03 | — | $0.87 |
| 2013 | $1.87 | $0.01 | $0.09 | −$0.00 | — | $1.02 |
| 2014 | $1.97 | −$0.22 | $0.11 | −$0.32 | — | $0.97 |
| 2015 | $1.96 | −$0.17 | $0.05 | −$0.11 | — | $0.97 |
| 2016 | $2.04 | −$0.30 | $0.08 | −$0.05 | — | $0.93 |
| 2017 | $2.21 | −$0.05 | $0.03 | $0.04 | — | $1.04 |
| 2018 | $2.74 | $0.11 | $0.05 | $0.23 | — | $3.00 |
| 2019 | $3.20 | $0.30 | $0.22 | $0.33 | — | $3.57 |
| 2020 | $3.41 | $0.12 | $0.18 | $0.26 | — | $4.24 |
| 2021 | $4.66 | $0.56 | $0.28 | $0.61 | — | $5.48 |
| 2022 | $4.85 | $0.80 | $0.37 | $0.36 | — | $6.97 |
| 2023 | $6.52 | $0.43 | $0.37 | −$0.07 | — | $7.90 |
| 2024 | $6.39 | −$0.41 | $0.48 | −$0.16 | — | $8.06 |
| 2025 | $4.83 | −$1.62 | $0.12 | −$0.81 | — | $6.97 |
Common questions about STAAR Surgical
How much does one share of STAAR Surgical earn?
Over the last 12 months, each share of STAAR Surgical earned $0.08 of profit on $6.73 of sales, keeping about 1¢ of every $1 (profit margin).
Does STAAR Surgical pay a dividend?
STAAR Surgical didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is STAAR Surgical’s book value per share?
STAAR Surgical’s book value is $7.29 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of July 3, 2026.
How much cash and debt does each share of STAAR Surgical have?
Each share of STAAR Surgical has $2.96 of cash and investments, as of July 3, 2026.
What is STAAR Surgical’s free cash flow per share?
−$0.13 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has STAAR Surgical bought back shares?
STAAR Surgical’s share count rose about 53% from 2009 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.